|
|
 |
|
Viewing report
|
|
 |
 |
European Metabolic Disease Therapy Markets
Frost & Sullivan, Feb 1999
An aging population and behavioral lifestyle changes are supporting the increasing incidence of metabolic diseases across Europe. This Frost & Sullivan report examines ongoing developments across this vast and dynamic industry. To provide a thorough overview of the European market, the report covers four disparate segments: diabetes, including both insulin and oral hypoglyceamic agents; obesity; growth hormones; and erythropoietin. The report provides information on market size and growth, market share, revenue forecasts, pricing strategy and trend analysis, the competitive structure, and more.
Customers who bought this item also bought
The Metabolic Syndrome
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Strategic Analysis of the Autoimmune Disease Diagnostics Market in Europe
Emerging Diagnostic Markers in Alzheimers Disease
Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics
Barriers to Effective Management of Metabolic Syndrome
Metabolic Syndrome - Multiple Definitions Complicate Treatment
Metabolic Diseases Pipeline Analysis:Focus on Dyslipidemia, Diabetes, and Obesity
|
 |
|
|